BRUSSELS (dpa-AFX) - The Switzerland market ended moderately higher on
Monday after staying firm right through the day's session, tracking positive
cues from other markets in the region.

Investors picked up stocks ahead of some crucial economic data, including a
report on Swiss inflation.

The benchmark SMI ended with a gain of 55.78 points or 0.47% at 12,049.61. The
index, which climbed to 12,103.30, touched a low of 12,022.16 in the session.

UBS Group climbed 2%. The bank announced the completion of the merger of its UBS
Switzerland unit and Credit Suisse (Schweiz), marking a key milestone in the
group's integration of Credit Suisse.

Julius Baer ended 1.67% up, while Swiss Life Holding, SIG Group, Straumann
Holding and Kuehne+Nagel gained 1.2 to 1.3%.

Givaudan, Sonova, ABB, Swiss Re, Zurich Insurance, Swisscom, Lindt & Spruengli,
Novartis and Swatch Group advanced 0.5 to 1%.

Nestle pared early gains and ended marginally higher. The stock rallied after
reports indicated that the Swiss food giant is anticipating stable growth with
positive volume and product mix contributions from the second quarter throughout
the remainder of the year.

Sika, VAT Group, Partners Group and Lonza ended lower by 0.4 to 0.8%. Sandoz
Group shares ended lower by 0.28%. The company announced that it has secured the
US Food and Drug Administration's approval of Pyzchiva for all indications of
the reference drug Stelara. The generics and biosimilar drugmaker also unveiled
plans to launch the psoriasis drug in the US in February 2025.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX